TY - JOUR
T1 - Characteristics of cases needing advanced treatment for intractable Posner-Schlossman syndrome
AU - Maruyama, Kazuichi
AU - Maruyama, Yuko
AU - Sugita, Sunao
AU - Mori, Kazuhiko
AU - Yokoyama, Yu
AU - Sanuki-Kunimatsu, Shiho
AU - Nakagawa, Hiroko
AU - Kinoshita, Shigeru
AU - Mochizuki, Manabu
AU - Nakazawa, Toru
N1 - Publisher Copyright:
© 2017 The Author(s).
PY - 2017/4/11
Y1 - 2017/4/11
N2 - Background: In Posner-Schlossman syndrome (PSS), which is characterized by recurrent unilateral attacks of ocular hypertension. Surgical treatment is sometimes necessary because intraocular pressure (IOP) cannot be controlled with anti-glaucoma medications. To identify the clinical features of Posner-Schlossman syndrome (PSS) indicative of the need for intraocular pressure (IOP)-controlling surgery. Methods: This study was a retrospective case-series analysis of the clinical charts of 33 patients diagnosed with PSS, who underwent surgery to control IOP or received medication only. Various clinical factors were compared between the surgical and medication groups. Results: The surgical group had a higher corneal endothelial cell (CEC) density loss (p < 0.05), higher maximum IOP (p < 0.01), greater visual field loss (p < 0.01) and higher positive number for cytomegalovirus (CMV) (p < 0.001) than the non-surgical group. Eighteen of the 33 patients had a high CEC reduction ratio. Of these 18, 16 required glaucoma surgery. Conclusions: PSS patients with a higher CEC reduction ratio, higher maximum IOP, greater visual field loss and higher positive number for CMV in the aqueous humor tended to be more likely to require progressive treatment, such as glaucoma surgery.
AB - Background: In Posner-Schlossman syndrome (PSS), which is characterized by recurrent unilateral attacks of ocular hypertension. Surgical treatment is sometimes necessary because intraocular pressure (IOP) cannot be controlled with anti-glaucoma medications. To identify the clinical features of Posner-Schlossman syndrome (PSS) indicative of the need for intraocular pressure (IOP)-controlling surgery. Methods: This study was a retrospective case-series analysis of the clinical charts of 33 patients diagnosed with PSS, who underwent surgery to control IOP or received medication only. Various clinical factors were compared between the surgical and medication groups. Results: The surgical group had a higher corneal endothelial cell (CEC) density loss (p < 0.05), higher maximum IOP (p < 0.01), greater visual field loss (p < 0.01) and higher positive number for cytomegalovirus (CMV) (p < 0.001) than the non-surgical group. Eighteen of the 33 patients had a high CEC reduction ratio. Of these 18, 16 required glaucoma surgery. Conclusions: PSS patients with a higher CEC reduction ratio, higher maximum IOP, greater visual field loss and higher positive number for CMV in the aqueous humor tended to be more likely to require progressive treatment, such as glaucoma surgery.
KW - Corneal endothelial cell (CEC) density
KW - Glaucoma surgery
KW - Intraocular pressure (IOP)
KW - Polymerase chain reaction (PCR)
KW - Posner-Schlossman syndrome (PSS)
UR - http://www.scopus.com/inward/record.url?scp=85018643082&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018643082&partnerID=8YFLogxK
U2 - 10.1186/s12886-017-0438-y
DO - 10.1186/s12886-017-0438-y
M3 - Article
C2 - 28399831
AN - SCOPUS:85018643082
SN - 1471-2415
VL - 17
JO - BMC Ophthalmology
JF - BMC Ophthalmology
IS - 1
M1 - 45
ER -